| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cg Oncology, Inc. (CGON) has 7 insiders with recent SEC Form 4 filings, including 1 buy and 14 sells. CGON is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.90M | $200.66M | - | |
| Dir | 1.52M | $104.70M | - | |
| Dir | 117.1K | $8.09M | - | |
| Dir | 24.2K | $1.67M | - | |
| Dir | 24.2K | $1.67M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 9, 2026 | Mulay James | Director | Sale+OE | 11,145 | $52.47 | $584,798.73 | -100% | +26.5% | - | |
| Nov 17, 2025 | Post Leonard E47 | Director | Sale+OE | 1,000 | $41.43 | $41,430.00 | -100% | +30.6% | - | |
| Oct 13, 2025 | Post Leonard E47 | Director | Sale+OE | 1,000 | $43.25 | $43,250.00 | -100% | +25.0% | - | |
| Oct 9, 2025 | Mulay James | Director | Sale+OE | 5,903 | $43.99 | $259,672.97 | -100% | -4.5% | - | |
| Sep 30, 2025 | Post Leonard E47 | Director | Sale+OE | 5,000 | $40.09 | $200,450.00 | -100% | -1.0% | - | |
| Sep 29, 2025 | Mulay James | Director | Sale+OE | 12,755 | $39.19 | $499,868.45 | -100% | +2.0% | - | |
| Sep 19, 2025 | Mulay James | Director | Sale+OE | 22,686 | $39.01 | $884,909.38 | -100% | +3.0% | - | |
| Sep 15, 2025 | Post Leonard E47 | Director | Sale+OE | 1,000 | $35.10 | $35,100.00 | -100% | +14.9% | - | |
| Sep 11, 2025 | Liu Brian Guan-Chyun | Director | Buy | 1,515,151 | $33.00 | $49,999,983.00 | New | +25.9% | - | |
| Sep 5, 2025 | Mulay James | Director | Sale+OE | 27,015 | $31.53 | $851,797.10 | -48.8% | +35.3% | - |